Jan 14, 2020 / 10:30PM GMT
Tycho W. Peterson - JP Morgan Chase & Co, Research Division - Senior Analyst
Okay. Good afternoon. We're going to go ahead and get started. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this afternoon, Agilent. Breakout's going to be right after in the Georgian Room across the hall. And with that, let me turn it over to Mike.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director
Thank you, Tycho, and thank you all for joining us this afternoon. I think it was 5 years ago I was the incoming CEO for Agilent Technologies. And I'm not sure if it was in this room or not, but at that time, I had talked about we really needed to go down a path of transforming the company. We had to get the growth rate of our company up. We had to get the profitability up. We had to get the earnings per share up, all to generate more value for our shareholders.
So what I thought I'd do today is touch on 3 things. First of all, so how did that story develop, how would you describe today's Agilent, the
Agilent Technologies Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers